Home > OJNeph>
Biography

Dr. Konstantinos Tziomalos

Aristotle University of Thessaloniki, AHEPA Hospital, Greece.

 

Email: ktziomalos@yahoo.com

 

Qualifications

2007  Ph.D., Aristotle University of Thessaloniki, Greece.

2003  M.Sc., Aristotle University of Thessaloniki, Greece.

1998  B.Sc., Aristotle University of Thessaloniki, Greece.

 

Publications

1.     Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome. Gynecol Endocrinol 2011 Jul 14.

2.     Athyros VG, Karagiannis A, Ganotakis E, Paletas K, Nicolaou V, Bacharoudis G, Tziomalos K, Alexandrides T, Elisaf MS, Mikhailidis DP; for the Assessing The Treatment Effect in Metabolic syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin 2011; 27: 1659-1668.

3.     Pagourelias ED, Gossios TD, Tziomalos K, Karagiannis A, Geleris P, Athyros VG. Residual cardiac risk reduction beyond lipid lowering. Hellenic J Cardiol 2011; 52: 197-203.

4.     Koiou E, Dinas K, Tziomalos K, Toulis K, Kandaraki EA, Kalaitzakis E, Katsikis I, Panidis D. The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria. Obes Facts 2011; 4: 145-150.

5.     Katsinelos P, Tziomalos K, Fasoulas K, Paroutoglou G, Koufokotsios A, Mimidis K, Terzoudis S, Maris T, Beltsis A, Geros C, Chatzimavroudis G. Can capsule endoscopy be used as a diagnostic tool in the evaluation of non-bleeding indications in daily clinical practice? A prospective study. Medical Principles and Practice 2011; 20: 362-367.

6.     Koiou E, Tziomalos K, Katsikis I, Kalaitzakis E, Kandaraki EA, Tsourdi EA, Delkos D, Papadakis E, Panidis D. Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. Eur J Endocrinol 2011; 165: 63-68.

7.     Athyros VG, Ganotakis E, Kolovou GD, Nicolaou V, Achimastos A, Bilianou E, Alexandrides T, Karagiannis A, Paletas K, Liberopoulos EN, Tziomalos K, Petridis D, Kakafika A, Elisaf MS, Mikhailidis DP; for the Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative. Assessing The Treatment Effect in Metabolic Syndrome without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women. Curr Vasc Pharmacol 2011 Apr 11.

8.     Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for cardiovascular risk and non alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011; 43: 167-171.

9.     Athyros VG, Karagiannis A, Tziomalos K, Gossios TD, Mikhailidis DP. Raised liver enzymes in patients taking statins. Lancet 2011; 377: 1075-1076.

10.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. Open Cardiovasc Med J 2011; 5: 24-34.

11.   Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases. Open Cardiovasc Med J 2011; 5: 85-89.

12.   Tsantilas D, Hatzitolios AI, Tziomalos K, Karamitsos D, Papadimitriou D. The effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy. Int Angiol 2011; 30: 164-171. 

13.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obes Rev 2011; 12: 515-524.

14.   Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J 2011; 58: 237-246.

15.   Panidis D, Tziomalos K, Koiou E, Kandaraki EA, Tsourdi E, Delkos D, Kalaitzakis E, Katsikis I. The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study. Reprod Biol Endocrinol 2010; 8: 151.

16.   Stavrinou E, Koumaras C, Gossios TD, Tziomalos K, Athyros VG, Karagiannis A. Atherosclerotic renal artery stenosis: an update on diagnosis and management. Curr Vasc Pharmacol 2010 Dec 14. [Epub ahead of print].

17.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr Pharm Des 2010; 16: 3839-3847.

18.   Athyros VG, Tziomalos K, Gossios TD, Griva T, Anagnostis P, Kargiotis K, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP; for the GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-1922.

19.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. To switch (statins) or not to switch? That is the question. Expert Opin Pharmacother 2010; 11: 2943-2946.

20.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Statin-fibrate combination for mixed dyslipidaemia: a limited option? Curr Med Res Opin 2010; 26: 2137-2140.

21.   Karagiannis A, Tziomalos K, Anagnostis P, Gossios TD, Florentin M, Athyros VG, Mikhailidis DP. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr Vasc Pharmacol 2010; 8: 792-803.

22.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Atorvastatin: Safety and tolerability. Exp Opin Drug Safety 2010; 9: 667-674.

23.   Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol 2010; 25: 394-398. 

24.   Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P, Krassas GE. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251-4257.

25.   Karagiannis A, Tziomalos K, Pagourelias ED, Gossios TD, Athyros VG. Effect of antihypertensive drug-associated diabetes on cardiovascular risk. Hellenic J Cardiol 2010; 51: 195-199.

26.   Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Management of statin-intolerant high-risk patients. Curr Vasc Pharmacol 2010; 8: 632-637.

27.   Agapakis DI, Tsantilas D, Psarris P, Massa EV, Kotsaftis P, Tziomalos K, Hatzitolios AI. Coagulation and inflammation biomarkers may help predict severity of community-acquired pneumonia. Respirology 2010; 15: 796-803.

28.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Lipid-lowering agents and new onset diabetes mellitus. Exp Opin Pharmacother 2010; 11: 1965-1970.

29.   Pagourelias ED, Giannoglou G, Kouidi E, Efthimiadis GK, Zorou P, Tziomalos K, Karagiannis A, Athyros VG, Geleris P, Mikhailidis DP. Brain natriuretic peptide and the athlete’s heart: a pilot study. Int J Clin Pract 2010; 64: 511-517.

30.   Karagiannis A, Tziomalos K, Mikhailidis DP, Semertzidis P, Kountana E, Kakafika AI, Pagourelias ED, Athyros VG. Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8,204 patients. Neurol Res 2010; 32: 326-31.

31.   Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Homocysteine: an emerging cardiovascular risk factor that never really made it. The Open Clinical Chemistry Journal 2010; 3: 19-24.

32.   Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Pitfalls in the evaluation of uric acid as a risk factor for vascular disease. The Open Clinical Chemistry Journal 2010; 3: 44-50.

33.   Athyros VG, Mitsiou EK, Tziomalos K, Karagiannis A, Mikhailidis DP. Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective? Curr Vasc Pharmacol 2010; 8: 1-4.

34.   Athyros VG, Tziomalos K, Karagiannis A, Wierzbicki AS, Mikhailidis DP. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? Curr Opin Cardiol 2010; 25: 406-410.

35.   Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol 2010; 16: 1587-1597.

36.   Tziomalos K. The effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B. World J Hepatol 2010; 2: 91-93.

37.   Tziomalos K, Dimitroula HV, Katsiki N, Savopoulos C, Hatzitolios AI. Effects of lifestyle measures, antiobesity agents and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm 2010; 2010: 364957.

38.   Athyros VG, Mitsiou EK, Tziomalos K, Karagiannis A, Mikhailidis DP. Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy. Expert Opin Pharmacother 2010; 11: 723-730.

39.   Anagnostis P, Karagiannis A, Tziomalos K, Athyros VG, Kita M, Mikhailidis DP. Endocrine hypertension: diagnosis and management of a complex clinical entity. Curr Vasc Pharmacol 2010; 8: 646-660.

40.   Kanashiro-Takeuchi RM, Tziomalos K, Takeuchi LM, Treuer AV, Lamirault G, Dulce R, Hurtado M, Song Y, Block NL, Rick F, Klukovits A, Hu Q, Varga JL, Schally AV, Hare JM. Cardioprotective effects of growth-hormone-releasing-hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A 2010; 107: 2604-2609.

41.   Athyros VG, Tziomalos K, Florentin M, Karagiannis A, Mikhailidis DP. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect? Curr Med Res Opin 2010; 26: 839-842.

42.   Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP. Comparison of four definitions of the metabolic syndrome in a Greek [Mediterranean] population. Curr Med Res Opin 2010; 26: 713-719.

43.   Vassiliadis T, Mpoumponaris A, Vakalopoulou S, Giouleme O, Gkissakis D, Grammatikos N, Soufleris K, Kakafika A, Tziomalos K, Patsiaoura K, Papanikolaou V, Evgenidis N. Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: incidence and correlation with disease severity and survival. Hepatol Res 2010; 40: 161-170.

44.   Katsiki N, Tziomalos K, Chatzizisis Y, Elisaf M, Hatzitolios AI. Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental? Atherosclerosis 2010; 211: 9-14.

45.   Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of treatment of obesity-related health problems? Curr Drug Targets 2010; 11: 122-135.